Phase 3, randomized, double-blind, controlled, efficacy, and safety study of a topical cream in participants age 12 and up with mild to moderate Hidradenitis Suppurativa

Phase 3, randomized, double-blind, efficacy and safety study of an oral agent in adults with moderate to severe Hidradenitis Suppurativa (and Long-Term Extension Study)

A Phase 3 randomized, double-blind, controlled, efficacy and safety study of a subcutaneous injection in adults with moderate to severe Hidradenitis Suppurativa

Phase 2b, randomized, double-blind, controlled, efficacy, and safety study of a subcutaneous injection in adults with moderate to severe Hidradenitis Suppurativa

Phase 3, open-label, single-arm study to evaluate pharmacokinetics and safety of a subcutaneous injection in adolescents, ages 12-17, with moderate to severe Hidradenitis Suppurativa